Stifel Initiates Coverage On AnaptysBio With Buy Rating, Announces Price Target of $50
Stifel Initiates Coverage On AnaptysBio With Buy Rating, Announces Price Target of $50
Stifel以买入评级启动对AnaptysBio的报道,宣布目标股价为50美元
Stifel analyst Alex Schwartz initiates coverage on AnaptysBio (NASDAQ:ANAB) with a Buy rating and announces Price Target of $50.
Stifel分析师亚历克斯·施瓦茨以买入评级开始对AnaptysBio(纳斯达克股票代码:ANAB)进行报道,并宣布目标股价为50美元。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。